PAREXEL Introduces Integrated Medical Writing Solutions Service Offering
PAREXEL International Corporation introduced PAREXEL's Medical Writing Solutions, a new offering that provides several communication services needed throughout each critical stage of the drug development and commercialization process.
The medical writing solutions team is made up of hundreds of trained experts that develop high quality documents which are compliant with the latest regulations and guidelines in order to drive value for clients.
The offering is currently available as both functional service projects or as part of larger strategic partnerships based on their study needs. For more information visit http://www.parexel.com/medicalwriting.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
